Iterative Scopes snags $150M in funding

Iterative Scopes obtained $150 million in series B funding to develop its artificial intelligence-powered gastroenterology technology, the company said Jan. 19. 

The financing comes after the company raised $30 million in August. 

Iterative Scopes will focus on inflammatory bowel disease and colorectal cancer prevention with the development of its AI technology products and services.  

The company offers an automated polyp detection tool, endoscopic scoring systems and a recruitment service for pharmaceutical companies to accelerate their IBD clinical trials.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

 

Thank you so much for your interest in our content. Please register to access this complimentary archived content.

 

 

Already Registered? Click here to confirm.